- Home
- QMCO vs AVTX Comparison
QMCO vs AVTX Comparison
Compare QMCO & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- AVTX
- Stock Information
- Founded
- QMCO 1980
- AVTX 2011
- Country
- QMCO United States
- AVTX United States
- Employees
- QMCO N/A
- AVTX N/A
- Industry
- QMCO Electronic Components
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- QMCO Technology
- AVTX Health Care
- Exchange
- QMCO Nasdaq
- AVTX Nasdaq
- Market Cap
- QMCO 61.3M
- AVTX 57.4M
- IPO Year
- QMCO N/A
- AVTX 2015
- Fundamental
- Price
- QMCO $8.82
- AVTX $4.89
- Analyst Decision
- QMCO Hold
- AVTX Strong Buy
- Analyst Count
- QMCO 2
- AVTX 7
- Target Price
- QMCO $19.00
- AVTX $31.00
- AVG Volume (30 Days)
- QMCO 1.2M
- AVTX 82.2K
- Earning Date
- QMCO 08-12-2025
- AVTX 08-11-2025
- Dividend Yield
- QMCO N/A
- AVTX N/A
- EPS Growth
- QMCO N/A
- AVTX N/A
- EPS
- QMCO N/A
- AVTX N/A
- Revenue
- QMCO $285,865,000.00
- AVTX $441,000.00
- Revenue This Year
- QMCO N/A
- AVTX N/A
- Revenue Next Year
- QMCO $2.46
- AVTX N/A
- P/E Ratio
- QMCO N/A
- AVTX N/A
- Revenue Growth
- QMCO N/A
- AVTX N/A
- 52 Week Low
- QMCO $2.22
- AVTX $3.39
- 52 Week High
- QMCO $90.64
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- QMCO 44.06
- AVTX 54.89
- Support Level
- QMCO $8.84
- AVTX $4.63
- Resistance Level
- QMCO $9.49
- AVTX $5.02
- Average True Range (ATR)
- QMCO 0.63
- AVTX 0.27
- MACD
- QMCO 0.06
- AVTX 0.00
- Stochastic Oscillator
- QMCO 63.70
- AVTX 72.73
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).